» Articles » PMID: 20504652

3,4-methylenedioxymethamphetamine (MDMA)-induced Release of Endogenous Serotonin from the Rat Dorsal Raphe Nucleus in Vitro: Effects of Fluoxetine and Tryptophan

Overview
Journal Neurochem Int
Specialties Chemistry
Neurology
Date 2010 May 28
PMID 20504652
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

The serotonin releasing action of 3,4-methylenedioxymethamphetamine on slices of dorsal raphe nucleus from rat was investigated. The slices were maintained in a gas-liquid interface perfusion chamber used for electrophysiological recording. Microdialysis probes designed for use on the slice surface were employed to measure the release of endogenous serotonin which was determined using liquid chromatography with electrochemical detection. Three minute duration exposure of the slices to 100 micromolar 3,4-methylenedioxymethamphetamine caused a long lasting release of endogenous serotonin. Fluoxetine, a serotonin transport inhibitor, reduced the amount of serotonin release. Tryptophan added to the perfusion solution increased both the duration and amount of serotonin released. These results further support earlier work on the mechanism of 3,4-methylenedioxymethamphetamine induced inhibition of serotonin neuronal firing.

Citing Articles

MDMA modulates spontaneous firing of subthalamic nucleus neurons in vitro.

Liebig L, von Ameln-Mayerhofer A, Hentschke H Exp Brain Res. 2014; 233(1):137-47.

PMID: 25234400 DOI: 10.1007/s00221-014-4095-6.


Behavioral and neurochemical effects of repeated MDMA administration during late adolescence in the rat.

Cox B, Shah M, Cichon T, Tancer M, Galloway M, Thomas D Prog Neuropsychopharmacol Biol Psychiatry. 2013; 48:229-35.

PMID: 24121061 PMC: 4348097. DOI: 10.1016/j.pnpbp.2013.09.021.


Differences in the locomotor-activating effects of indirect serotonin agonists in habituated and non-habituated rats.

Halberstadt A, Buell M, Price D, Geyer M Pharmacol Biochem Behav. 2012; 102(1):88-94.

PMID: 22487771 PMC: 3354037. DOI: 10.1016/j.pbb.2012.03.023.


Contributions of serotonin in addiction vulnerability.

Kirby L, Zeeb F, Winstanley C Neuropharmacology. 2011; 61(3):421-32.

PMID: 21466815 PMC: 3110503. DOI: 10.1016/j.neuropharm.2011.03.022.


Causes and consequences of the loss of serotonergic presynapses elicited by the consumption of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") and its congeners.

Huether G, Zhou D, Ruther E J Neural Transm (Vienna). 1997; 104(8-9):771-94.

PMID: 9451711 DOI: 10.1007/BF01285547.